Clinical Practice, Patient-Physician Relationship and Computers

Author(s):  
Alvaro Díaz Berenguer
2020 ◽  
Vol 7 (3) ◽  
pp. HEP26
Author(s):  
John C McVey ◽  
Kazunari Sasaki ◽  
Daniel J Firl

Liver transplantation for hepatocellular carcinoma has proved to be a highly effective cure if the right patient can be selected. Milan criteria has traditionally guided physicians toward appropriate liver allocation but changes in clinical practice, patient populations and recent developments in biomarkers are decreasing Milan criteria’s utility. At the same time, the literature has flooded with a diversity of new criteria that demonstrate strong predictive power and are better suited for current clinical practice. In this article, the utility of newly proposed criteria will be reviewed and important issues to improve future criteria will be addressed in hopes of opening a discussion on how key questions surrounding criteria for liver transplantation of hepatocellular carcinoma can be answered.


2005 ◽  
Vol 13 (2) ◽  
pp. 140-147 ◽  
Author(s):  
John Little ◽  
Jo Munday ◽  
Martin Atkins

Objective: Specific guidelines, ongoing controversies in technique and audit reviews have made clinicians wary about continuing in electroconvulsive therapy (ECT). This paper attempts to reassure practitioners by incorporating such changes into a simple approach to ECT based on outcomes equivalence. Method: A selected compilation of the recent literature was used to describe a model for starting and/or continuing an effective ECT service. Results: It was suggested that a useful way of approaching ECT service delivery is to focus on what is actually important, getting patients better, and to do so within the context and capability of each hospital. Conclusions: ECT is a changing field. Remaining true to the core principles of clinical practice, patient selection and technique, provides a basis for beginning, continuing and further developing an effective ECT service.


2012 ◽  
Vol 18 (5) ◽  
pp. 660-667 ◽  
Author(s):  
Cheryl Rosenfeld ◽  
Nancy Bohannon ◽  
Bruce Bode ◽  
Adam Kelman ◽  
Shari Mintz ◽  
...  

2018 ◽  
Vol 12 (4) ◽  
pp. 265-269
Author(s):  
Davide Donelli ◽  
Michele Antonelli ◽  
Matteo Rizzato ◽  
Lorenzo Morini

Empathy markedly influences the patient-physician relationship and, consequently, the patient’s experience. When relating with patients, empathic disconnection (ED), a condition characterized by a reduction of the empathic response, often occurs. During clinical practice, it is important to recognize and possibly avoid ED in order to improve the patient-physician relationship. Some of the most common scenarios which lead to ED in clinical practice are countertransference hate, moral judgement, reactive physical discomfort, and labelling. Although many strategies may be adopted by the physician to empower empathy in the patient-physician relationship, the focus should be in the first place on paying attention to communication process during clinical practice. Being able to recognize situations characterized by ED in order to prevent them can improve the patient’s experience. Further research is needed to investigate this aspect of the patient-physician relationship and its impact on clinical outcomes.


2019 ◽  
Vol 37 (27_suppl) ◽  
pp. 39-39
Author(s):  
Kathy Vu ◽  
David Warr ◽  
Leta Marie Forbes ◽  
Daniela Gallo-Hershberg ◽  
Carlo DeAngelis ◽  
...  

39 Background: Cancer Care Ontario (CCO) last updated their guidance for the management of chemotherapy-induced nausea and vomiting (CINV) in 2013. Since then, new evidence emerged which changed antiemetic recommendations internationally. The CCO Antiemetic Working Group reviewed the current literature and updated existing recommendations for the prevention and management of CINV in adult patients. Methods: Ontario subject matter experts consisting of oncologists, pharmacists and nurses formed the Group. Relevant guidelines published from prominent jurisdictions were assessed. A literature search was done to incorporate the latest evidence. All chemotherapy regimens in the CCO Drug Formulary were reviewed. Ontario Cancer Leads for each disease site were consulted to ensure emetic classifications for all regimens and antiemetic recommendations reflected both the evidence (including gaps in the literature) and clinical practice (including gaps between evidence and practice). Results: Recommendations for antiemetic agents for highly, moderately, low and minimal emetic risk intravenous and oral chemotherapy are outlined. Chemotherapy regimens in the CCO Drug Formulary were reviewed and emetic risks updated. Recommendations differed from those of major international guidelines (including ASCO) around olanzapine dosing, cannabinoids and emetic risk classification. Conclusions: A systematic approach to updating antiemetic recommendations resulted in evidence-informed recommendations that are patient-focused and clinically feasible.


Sign in / Sign up

Export Citation Format

Share Document